Sodium Nitroprusside Injection, Solution, Concentrate
Product Images NDC 70069-261

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 70069-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5e39cef4 Deb1 4512 974e 25e4fa0447db 01)

Chemical structure of sodium nitroprusside showing an iron (Fe) center coordinated to five cyanide (CN) groups and one nitrosyl (ON) group, with two sodium ions (Na+) and two water molecules (H2O) included.*

FDA Label Image

Image (5e39cef4 Deb1 4512 974e 25e4fa0447db 02)

An illustration diagram titled 'Metabolism of Sodium Nitroprusside' showing biochemical pathways and interactions involving cytochromes, nitroprusside, cyanide, methemoglobin (metHgb), thiosulfate, thiocyanate, and renal excretion processes. Arrows indicate the metabolic flow directions and enzymatic transformations such as those catalyzed by rhodanase.*

FDA Label Image

Container Label (5e39cef4 Deb1 4512 974e 25e4fa0447db 03)

Label for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) single-dose vial, manufactured for Somerset Therapeutics, LLC. The label indicates intravenous infusion use only, instructs protection from light, and storage at 20° to 25°C. Includes NDC 70069-261-01, barcode, and manufacturer contact information.*

FDA Label Image

Carton Label (5e39cef4 Deb1 4512 974e 25e4fa0447db 04)

Packaging label for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) concentrate solution for intravenous infusion by Somerset Therapeutics LLC. The carton includes dilution and storage instructions, dosage form, and cautions such as monitoring blood pressure, protecting from light, and discarding solution 24 hours after dilution. It contains a 2 mL single-dose vial with NDC 70069-261-01.*

FDA Label Image

Light Protective Sleeve Label (5e39cef4 Deb1 4512 974e 25e4fa0447db 05)

Label for Sodium Nitroprusside Injection (Infusion) by Somerset Therapeutics, LLC. The label includes spaces to fill in mg and mL of 5% Dextrose Injection, with instructions to protect the solution from light and discard 24 hours after dilution. It states the solution must be covered with a light protective sleeve or opaque material. The label is marked as made in India, with customer care contact and revision date 05/2025.*

FDA Label Image

Sleeve Box Label (5e39cef4 Deb1 4512 974e 25e4fa0447db 06)

Text panel indicating the product Sodium Nitroprusside (Infusion) contains a light protective sleeve. It instructs that the infusion solution must be protected from light by covering with the enclosed light protective sleeve or other opaque material. The text is repeated with a revision date of 11/2019.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.